Pompe Disease Clinical Trials | Amicus Therapeutics

A Thank You to All Participants: At Amicus, we believe that all study participants are equal clinical research partners in the drug development process.  Without the support of their families, friends, and healthcare teams, the Amicus clinical research program could not move forward.  Amicus would like to express its gratitude to the Pompe community and all involved in the ongoing and completed clinical trials and all of our clinical research.

AT-GAA: Phase 1/2 Safety Study (ATB200-02 Study)

More information: www.clinicaltrials.gov: NCT02675465

 

AT-GAA: PHASE 3 PROPEL STUDY (ATB200-03 STUDY)

More information: www.clinicaltrials.gov: NCT03729362

Official PROPEL study website: www.pompestudy.com